Oncology
Moving PARP Inhibition Upfront: Why the Phase 3 TALAPRO-3 Trial Rewrites Treatment for HRR-Deficient mCSPC
From Late to Early Intervention: Advanced Prostate Cancer Treatment.
Rayan Salih · June 10, 2026 · 9 min
Living with Prostate Cancer
Stories from people navigating Prostate Cancer — diagnosis, treatment, caregiving, and the ordinary days in between.
4 stories
Oncology
FDA Approves Pylarify TruVu to Expand PSMA-PET Imaging Access for Prostate Cancer
The Food and Drug Administration has approved the use of Pylarify TruVu, which is an updated version of
Dr. Abu Bakar · 8 min read
Clinical Briefs
When To Start Prostate Cancer Screening In Men: Considerations
Screening for prostate cancer has become routine, but guidelines for screening are evolving.
Dr. Abu Bakar · 12 min read
Oncology
Prognostic Model for Clinically Significant Prostate Cancer Developed
A model for predicting the presence of clinically significant prostate cancer (csPCa) using imaging, clinical and patient specific
Dr. Abu Bakar · 8 min read
Other conditions
One story a day
The story of the day, in your inbox
One health journey each morning — no advice, no alarm, just company for the road.